Skip to main content
TipRanks
Go Ultimate75% OFF

ZYUS Life Sciences (ZYUS) Stock Statistics & Valuation Metrics

8 Followers

Total Valuation

ZYUS Life Sciences has a market cap or net worth of CAD 31.00M. The enterprise value is CAD 67.01M.

Market Cap
CAD 31.00M
Enterprise Value
CAD 67.01M

Share Statistics

ZYUS Life Sciences has 80,522,810 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
80,522,810
Owned by Insiders
93.88%
Owned by Institutions
―

Financial Efficiency

ZYUS Life Sciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
7,813.418
Employee Count
55
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, ZYUS Life Sciences had revenue of ― and earned 429.74K in profits. Earnings per share was ―.

Revenue
―
Gross Profit
-1,012
Operating Income
-294.26K
Pretax Income
―
Net Income
429.74K
EBITDA
-294.26K
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
0.36
52-Week Price Change
-46.38%
50-Day Moving Average
0.48
200-Day Moving Average
0.52
Relative Strength Index (RSI)
40.12
Average Volume (3m)
15.63K

Important Dates

ZYUS Life Sciences upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Nov 26, 2026
Ex-Dividend Date
―

Balance Sheet

ZYUS Life Sciences has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 0.00
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for ZYUS Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-22.57%
EPS Growth Forecast
46.77%